Inbal Halevy-Hazan
Jaffa, TA, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Harnessing the endosomal escape compartment as a strategy to enhance RNA delivery via lipid nanoparticles.
Journal: Molecular therapy. Nucleic acids
Published: August 07, 2026
cSMRTS for cancer therapeutics.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: December 10, 2025
Novel Bivalent mRNA-LNP Vaccine for Highly Effective Protection against Pneumonic Plague.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 20, 2025
Targeting intestinal inflammation using locked nucleic acids delivered via lipid nanoparticles.
Journal: Nature communications
Published: October 29, 2024
Targeted CRISPR/Cas9 Lipid Nanoparticles Elicits Therapeutic Genome Editing in Head and Neck Cancer.
Targeted CRISPR/Cas9 Lipid Nanoparticles Elicits Therapeutic Genome Editing in Head and Neck Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: September 09, 2024
The future of genetic medicines delivered via targeted lipid nanoparticles to leukocytes.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: July 05, 2024
Unlocking the therapeutic potential of locked nucleic acids through lipid nanoparticle delivery.
Journal: Molecular therapy. Nucleic acids
Published: June 27, 2024
Delivery of nucleic acid based genome editing platforms via lipid nanoparticles: Clinical applications.
Journal: Advanced drug delivery reviews
Published: March 30, 2024
Targeting cancer with mRNA-lipid nanoparticles: key considerations and future prospects.
Journal: Nature reviews. Clinical oncology
Published: July 25, 2023
Therapeutic gene silencing of CKAP5 leads to lethality in genetically unstable cancer cells.
Journal: Science advances
Published: April 05, 2023
A Combinatorial Library of Lipid Nanoparticles for Cell Type-Specific mRNA Delivery.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 25, 2023
A single-dose F1-based mRNA-LNP vaccine provides protection against the lethal plague bacterium.
Journal: Science advances
Published: March 08, 2023
Last Updated: 09/26/2026